Shawn Boyle

Lobbying Global Affairs Canada to increase investment in programs and policies that will improve access to justice to women and children experiencing violence. Introducing International Justice Mission's programs in Latin America to end violence against women and children. Lobbying for legislation, policies, law enforcement and investments that will prevent the online sexual exploitation of children.

Free trade agreements as they relate to biomanufacturing industry in Canada Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to provide industry recommendations on Canada's Biomanufacturing and Life Sciences Strategy, National Pharmacare, Intellectual property as well as pricing reforms (PMPRB) Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada. R&D requirements set forth through the Patent Medicines Pricing Review Board (PMPRB) Patent Medicines Pricing Review Board reforms, regarding both the revised regulations and draft guidelines Patented Medicines (Notice of Compliance) Regulations as it relates to regulation of intellectual property for therapeutic products. Novartis is working with our industry associations (Innovative Medicines Canada and BIOTECanada) to provide a written response to Guideline consultation process and will provide our own corporate submission. Patented Medicine Prices Review Board (PMPRB) Regulations as related to reporting requirements and pricing guidelines. Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda. Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.

- Partnership discussions with Canadian Commercial Corporation and/or Export Development Canada. - Issues pertaining to OPG's existing nuclear operations or new nuclear opportunities in regards to Atomic Energy of Canada Limited (AECL). - Re - the Fisheries Act encouraging regulatory reform, harmonization and equivalencies amongst the regulators to reduce duplication and encourage more efficient use of resources while continuing to manage risk of existing OPG operations as it relates to fish and fish habitat. - Re - Nuclear Liability and Compensation Act with regard to language, timing and liability limit, insurance requirements and to make it compatible with the Convention of Supplementary Compensation. - Regulatory Framework for Industrial Greenhouse Gas Emissions in Canada in respect to controlling greenhouse gas and conventional air pollutant emissions in the electricity sector including advocating for a role of nuclear energy in meeting targets Regulatory approach to prohibit asbestos and products containing asbestos including advocating for reasonable timeframe to phase out all asbestos containing products. - Regulations to reduce Green House Gas (GHG) emissions from the electricity sector’s fossil fuel-fired electricity generation units, advocating the role that existing and uprated natural gas plants play in the electricity market and seeking compliance flexibility for thermal units burning gas to provide grid reliability due to regulation. Advocating for the development of low-emitting Nuclear, Hydroelectric and Hydrogen Developments in meeting targets. Regulations regarding requirements and guidance for managing fitness for duty of workers in relation to alcohol and drug use and abuse at high-security sites. Regulations regarding polychlorinated biphenyls (PCB). - Re - Federal Waterways with respect to developing tangible actions for and improved policy and practical business practices among infrastructure and operators. Investment discussions with Canada Infrastructure Bank and Canada Growth Fund Inc. Issues pertaining to federal legislation, policies and programs with respect to OPG's existing nuclear operations or new nuclear opportunities including small modular reactors (SMRs). Issues pertaining to federal legislation, policies and programs with respect to hydrogen. Issues pertaining to federal legislation, policies and programs related to energy storage facilities. Issues pertaining to federal legislation, policies, programs, and permits and other approvals affecting OPG’s current operations as well as other potential opportunities including in the areas of new generation development and/or other economic opportunities including electrification, as well as to support collaboration and partnership between Indigenous communities and OPG. - In respect to the Protection of Electricity Critical Infrastructure in Canada, including expediting background checks for prospective employees and contractors, changes to the Criminal Code of Canada relating to "Interference with Electricity Critical Infrastructure" (copper wire theft), "Priority Access for Electricity Critical Infrastructure Personnel to receive Vaccinations and Antivirals" and priority access to "Telecommunications Spectrum". Discussion on subjects related to the MOU signed by Canada and the ITER (International Thermonuclear Experimental Reactor) to help identify the precise domains in which Canadian suppliers could export expertise and technologies on a commercial basis to the ITER Project and OPG’s interest in leading and acting as an agent for the cooperation with ITER. - Changes to the Impact Assessment Act or implementing regulations, including towards achievement of improved alignment with the ongoing licensing process for nuclear facilities under the Nuclear Safety and Control Act. - Changes to the Canada Labour Code as they apply to nuclear new build activities in respect to allowing coordination between provincial and federal labour requirements App